A Comparative Treatment Results of Oesophageal Squamous Cell Carcinoma by Neoadjuvant Chemotherapy followed by Radiotherapy versus Radiotherapy Alone
DOI:
https://doi.org/10.3329/jom.v8i2.1409Abstract
Background: Studies suggest that neoadjuvant chemotherapy prior to radiotherapy results in improved response and survival in large primary lesion. This study aimed to evaluate the role of neoadjuvant chemotherapy prior to radiotherapy in patients with localized oesophageal cancer.
Method: In this randomized controlled study 60 selected cases of oesophageal squamous cell carcinoma were randomized to Arm-A & Arm-B. Patients assigned to combination therapies(Arm- A) received two cycles (4 weekly) of injectable 5- fluorouracil(400mg/m2/day for five days ) and mitomicin C (7mg/ m2 on D1) as neoadjuvant chemotherapy prior to radiotherapy(44GY in 22 fractions). Patients of Arm-B received radiotherapy alone as in arm-A. Treatment responses were compared following completion of treatment at six and 12 weeks. Complete response was defined as no difficulty in swallowing and no visible growth in follow-up barium swallow X-Ray. Partial response was defined as difficulty in swallowing semisolids but not liquids and persistence of residual growth in barium swallow X-Ray.
Results: The study initially enrolled 68 patients but eight patients dropped out. Complete response occurred in 66.6% (20) patients who received combination therapies (n=30), where as in 40% (12) patients who received radiotherapy alone (P= < 0.05). Partial response occurred in 33.33% patients assigned to have pre-irradiation chemotherapy and in 60% patients having radiotherapy alone. Toxicities like dysphagia, anorexia, vomiting was more in combination therapy group, but it was acceptable.
Conclusion: Neoadjuvant chemotherapy followed by radiation therapy demonstrated better response than radiation alone at the expense of toxicity in patients with localized oesophageal cancer.
 DOI = 10.3329/jom.v8i2.1409
J MEDICINE 2007; 8 : 60-63
Downloads
100
55
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).